Research specializing in cognitive neuropsychology, neuroimaging, cultural psychology (disaster management) and mental health.
Specializing in brain-related disorders including
dyslexia, affective disorders (including bipolar disorder and major depressive disorder), psychosis, attention deficit hyperactivity disorder, Alzheimer's disease, traumatic brain injury, ischemic/hemorrhagic
Our research has focused on integrating neuropsychological measures, cognitive measures, and neuroimaging techniques with genetic and developmental data, comprised of neurological patients, psychiatric patients, and control subjects.
For more information on ongoing research, contact us.
Dr. Jogia published the first studies to assess Lamotrigine (LTG) monotherapy in bipolar disorder. The results of these studies provide evidence for the ‘normalisation’ effect LTG may have on key prefrontal regions associated with emotional self-regulation - akin to what has been observed with successful remission of depression.
Another of Dr. Jogia's recent studies provided the first formal evidence of a disease-specific influence of the CACNA1C (rs1006737) genotype on brain function. This influence was found to be present in the ventral lateral prefrontal cortex (PFC) during emotional processing in bipolar patients carrying the risk allele, but absent in unaffected relatives.
A recent study published by Dr. Jogia was the first study to use pattern recognition (a form of machine learning) for the diagnostic classification of patients with bipolar disorder based on neuroanatomical data. Being able to identify and differentiate disorders based on neurobiology is regarded as the “Holy Grail” within psychiatric research; this project, therefore, was a significant advancement. This technique can also be used to investigate the efficacy of drug therapy on brain-related disorders.